-
Medtronic To Face Class Action Suit From Canadian Users Of MiniMed Insulin Pumps
Thursday, October 28, 2021 - 3:59pm | 281A national class action in Canada has been commenced against Medtronic Plc (NYSE: MDT) over its MiniMed 630G and 670G insulin pumps. Rochon Genova and Cardill Law commenced the proposed class-action suit against Medtronic, Medtronic MiniMed, and Medtronic of Canada over the...
-
FDA Clears Use Of Eli Lilly's Insulin With Insulet's Infusion Pumps
Monday, August 16, 2021 - 3:01pm | 180The FDA has approved the use of Eli Lilly And Co's (NYSE: LLY) Lyumjev (insulin lispro-aabc injection) 100 units/mL with Insulet Corporation's (NASDAQ: PODD) insulin management systems. Lyumjev, approved by the FDA in June 2020, is a formulation of insulin...
-
Tandem Diabetes Rallies After FDA Approves Insulin Pump With New Technology
Friday, June 22, 2018 - 10:34am | 401Tandem Diabetes Care Inc (NASDAQ: TNDM) shares were rallying Friday following FDA approval of the company's new insulin pump. Tandem Diabetes were trading up 12.4 percent to $22.83 at the time of publication Friday morning. What Happened The medical device maker...